ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation
about
The impact of the inpatient practice of continuous deep sedation until death on healthcare professionals' emotional well-being: a systematic review.Addressing Palliative Sedation during Expert Consultation: A Descriptive Analysis of the Practice of Dutch Palliative Care Consultation Teams.Conclusiveness of the Cochrane Reviews in Palliative and Supportive Care for Cancer.Sedation at the end of life - a nation-wide study in palliative care units in Austria.Palliative Sedation in Patients With Cancer.Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidol.Hypoalbuminaemia and decreased midazolam clearance in terminally ill adult patients, an inflammatory effect?Walking the line. Palliative sedation for existential distress: still a controversial issue?Clinical Assessment and Management of Delirium in the Palliative Care SettingContinuous palliative sedation for patients with advanced cancer at a tertiary care cancer center.Efficacy of two types of palliative sedation therapy defined using intervention protocols: proportional vs. deep sedation.Population pharmacodynamic modelling of midazolam induced sedation in terminally ill adult patients.[Austrian guideline for palliative sedation therapy (long version) : Results of a Delphi process of the Austrian Palliative Society (OPG)].Palliative Sedation and What Constitutes Active Dying: A Case of Severe Progressive Dystonia and Intractable Pain.The Limits of Surrogates' Moral Authority and Physician Professionalism: Can the Paradigm of Palliative Sedation Be Instructive?
P2860
Q33651385-FC90945E-D2DE-4E99-8E16-00B13E22981EQ35753648-605A5E9F-7F51-4DA3-BCC4-7BA3F1DA04CFQ35768518-C2970C26-4F15-441E-8AB7-9187CDC57BC9Q36018135-A1FAEE26-1DAE-4E0D-9F63-D6B5C11E3C2AQ38672369-84643FB3-847E-4267-B3DA-2B1FA64CAC94Q38809021-A8904637-0281-45BF-AA92-9E6965E4B7CFQ38972539-9B5B1C32-32EE-4AA2-A096-D5956605CE9FQ39179925-0A61EA35-7227-4B58-829F-3F012CE9FD1DQ42182792-EA336948-7C48-44D5-9682-C641D70CE157Q47169337-57D2C174-5742-4D43-ACEC-7E7497F4D0CCQ47305927-638F4101-4E25-44D1-8F8A-6D3170995B98Q47901754-1B45732C-2FBD-477E-8255-A784330B9F24Q48177338-0CC7D854-6F5D-4913-936F-500631EBEDDAQ48419759-2F0C1571-3D3D-4BC5-9BF0-EC3CBD116EA6Q52758595-9AF4E0C0-3595-4EBF-90A4-BC837DDD0945
P2860
ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation
description
im September 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 September 2014
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2014
@uk
name
ESMO Clinical Practice Guideli ...... the use of palliative sedation
@en
ESMO Clinical Practice Guideli ...... the use of palliative sedation
@nl
type
label
ESMO Clinical Practice Guideli ...... the use of palliative sedation
@en
ESMO Clinical Practice Guideli ...... the use of palliative sedation
@nl
prefLabel
ESMO Clinical Practice Guideli ...... the use of palliative sedation
@en
ESMO Clinical Practice Guideli ...... the use of palliative sedation
@nl
P2860
P356
P1433
P1476
ESMO Clinical Practice Guideli ...... the use of palliative sedation
@en
P2093
ESMO Guidelines Working Group
N I Cherny
P2860
P304
P356
10.1093/ANNONC/MDU238
P433
P478
25 Suppl 3
P577
2014-09-01T00:00:00Z